论文信息 - Efficacy of Stronger Neo‐Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis - 字舞流文

Efficacy of Stronger Neo‐Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis

Background: A daily injection of glycyrrhizin (Stronger Neo‐Minophagen C (SNMC) containing 40 mg glycyrrhizin in a 20 mL ampoule) lowers alanine aminotransferase (ALT) levels in patients with chronic viral hepatitis.

T. Tango | Katsuaki Tanaka | S. Hayashi | S. Iwabuchi | M. Yoshiba | Y. Endo | N. Hashimoto | Yuzuru Sato | K. Mitamura | Y. Ikeda | Hiroshi Suzuki | M. Kako | K. Miyake | T. Umeda | N. Hayashida | J. Miyazaki | Y. Ota | Toshiaki Tomi | N. Funaki

[1] Tango,et al. Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis. , 2001, Hepatology research : the official journal of the Japan Society of Hepatology.

[2] W. Hop,et al. Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double‐blind, randomized, placebo‐controlled phase I/II trial , 1999, Journal of gastroenterology and hepatology.

[3] K. Chayama,et al. The long term efficacy of glycyrrhizin in chronic hepatitis C patients , 1997, Cancer.

[4] N. Hayashi,et al. Effect of glycyrrhizin on viral replication and quasispecies in patients with type C chronic hepatitis , 1997 .

[5] K. Fujisawa,et al. Therapeutic Approach to the Chronic Active Liver Disease: Summary of a Satellite Symposium , 1994 .